Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Terminated 4Withdrawn 3Unknown 2Not yet recruiting 2Completed 2Recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma 2Salivary Gland Neoplasms 1Lung Neoplasms 1Hemangioma, Cavernous, Central Nervous System 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × DNA × Clear all
NCT03474614 2024-04-19

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

St. Joseph's Hospital and Medical Center, Phoenix

Phase 2 Terminated
4 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

NCT00793208 2019-04-12

Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)

University of Pittsburgh

Phase 1 Terminated
1 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00377247 2016-07-11

Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor

University of Pittsburgh

Phase 1 Terminated
5 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma

NCT00898742 2013-04-02

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Terminated
58 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡